Search

everythinglearnresearchcommunity

for

Search:↓

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

Certain medications can cause serious side effects, so it's important to report them.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

ATP helps prevent skin damage from vandetanib by reducing stress.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Tolvaptan can slow kidney disease progression, but doesn't affect mortality or kidney failure.

New medications could improve treatment for severe alopecia areata in Australia.

Modulating Cytochrome P450 activity could help develop new skin disease treatments.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

Baricitinib effectively reduces hair loss in severe alopecia areata and is generally safe.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

TNF-α inhibitors may cause complete hair loss in some patients with ankylosing spondylitis.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Letrozole may help prevent seizures by reducing certain hormone levels.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

New compounds may soon be tested to treat excessive hair growth in women.